Comparison Overview
SIRION BIOTECH GmbH (Revvity Gene Delivery)

SIRION BIOTECH GmbH (Revvity Gene Delivery)
Am Haag 6, Gräfelfing, Bavaria, 82166, DE
Last Update: 26/02/2026
Viral Vector Services from Vector Engineering and Manufacturing to Cell and Gene Therapy Development Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical app...

Agilent Technologies
5301 Stevens Creek Boulevard, Santa Clara, 95051, US
Last Update: 11/09/2026
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them...
Compliance Ranges Comparison

SIRION BIOTECH GmbH (Revvity Gene Delivery)







Agilent Technologies






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for SIRION BIOTECH GmbH (Revvity Gene Delivery) in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Agilent Technologies in 2026.
Incident History - SIRION BIOTECH GmbH (Revvity Gene Delivery) (X = Date, Y = Severity)
SIRION BIOTECH GmbH (Revvity Gene Delivery) cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Agilent Technologies (X = Date, Y = Severity)
Agilent Technologies cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

SIRION BIOTECH GmbH (Revvity Gene Delivery)

Agilent Technologies
FAQ
Latest Global CVEs
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to exposure of session tokens in the HTML response.
IBM TRIRIGA Application Platform 5.0.0 through 5.0.8 could allow a remote authenticated attacker to obtain sensitive information due to an XML external entity (XXE) injection flaw.
IBM Aspera Enterprise WebApps 1.0.0 through 1.0.6 could allow a local attacker to obtain sensitive information due to cleartext transmission of sensitive information.
IBM Planning Analytics 2.0, and 2.1 could allow a remote authenticated attacker to execute arbitrary code due to a stack-based buffer overflow.
IBM DataStage on Cloud Pak for Data 5.4.0.0 can allow a man-in-the-middle attacker to present a forged TLS certificate, intercept the connection, and capture the IAM bearer Authorization header automatically attached by the session adapter. The captured token grants full platform-scope tenant API access, enabling the attacker to read and manipulate the victim's DataStage projects, flows, assets, and pipeline definitions. This is client-side SDK code running on the user's own machine, so exploitation requires an external network interceptor rather than a co-tenant in the shared cluster.